GoodRx vs MyDietDoc: Prices, Programs & Reviews (2026)
Side-by-side comparison updated for 2026. ClearScores, pricing, medications, and ratings compared.
Quick Verdict
MyDietDoc has the higher ClearScore (82 vs 72)
GoodRx is more affordable ($119/mo vs $274/mo)
GoodRx scores better on value (4.4/5 vs 3.5/5)
GoodRx
$119/mo
starting price
Trusted prescription savings brand now offering GLP-1 telemedicine with $199 introductory Wegovy/Ozempic pricing.
MyDietDoc
$274/mo
starting price
Same-day doctor consultations, included nutritionist, and anti-nausea meds with every GLP-1 program. 10+ years in business.
GoodRx vs MyDietDoc: Full Comparison
| GoodRx | MyDietDoc | |
|---|---|---|
| ClearScore | 72/100 | 82/100 ✓ |
| Overall Rating | 4/5 | 4/5 |
| Review Count | 89 | 129 ✓ |
| Starting Price | $119/mo ✓ | $274/mo |
| Medications | Branded Semaglutide, Branded Tirzepatide | Compounded Semaglutide, Compounded Tirzepatide, Sermorelin ✓ |
| Telehealth | Yes | Yes |
| Insurance | Not accepted | Not accepted |
| HSA/FSA | Accepted | Accepted |
| Founded | 2011 | 2012 |
| States Served | All 50 states | All 50 states |
Programs & Pricing
GoodRx Programs
GoodRx for Weight Loss
$119/mo + medication
Medications: Branded Semaglutide, Branded Tirzepatide
- Clinician Consultations
- Ongoing Support
- Prescription Savings
- Flexible Fulfillment
MyDietDoc Programs
Semaglutide Program
~$274/mo
Medications: Compounded Semaglutide
- Medication
- Doctor Consultations
- Nutritionist Support
- Anti Nausea Medication
Tirzepatide Program
$600/program
Medications: Compounded Tirzepatide
- Medication
- Doctor Consultations
- Nutritionist Support
Ratings Breakdown
| Category | GoodRx | MyDietDoc |
|---|---|---|
| Overall | | |
| Value | | |
| Ease of Use | | |
| Support | | |
| Medication Quality | | |
| Results | | |
The Bottom Line
MyDietDoc edges out GoodRx with a ClearScore of 82 vs 72. GoodRx is more affordable starting at $119/mo compared to $274/mo. For customer support, MyDietDoc rates higher (4.2/5). The best choice depends on your priorities, medication preferences, and budget.